Feedback

X
Advances in the Treatment of Renal Cell Carcinoma

Advances in the Treatment of Renal Cell Carcinoma

0 Ungluers have Faved this Work
This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 55 times via unglue.it ebook links.
  1. 55 - pdf (CC BY) at Unglue.it.

Keywords

  • artesunate (ART)
  • Autophagy
  • biomarker
  • biomarkers
  • ccRCC
  • chloroquine
  • clear cell renal cell carcinoma
  • cysteine cathepsin inhibitors
  • cysteine cathepsins
  • Evolution
  • evolutionary trajectory
  • ferroptosis
  • genomic signature
  • growth inhibition
  • hydroxychloroquine
  • immune checkpoint inhibitors
  • immune-based combination therapies
  • Immunotherapy
  • Individualization
  • kidney cancer
  • lysosome
  • medicine
  • metastatic
  • metastatic renal cell carcinoma
  • mRCC
  • network meta-analysis
  • PD-L1
  • predictive
  • RCC
  • reactive oxygen species (ROS)
  • renal cancer
  • renal cell cancer
  • renal cell carcinoma
  • Renal cell carcinoma (RCC)
  • ROC-325
  • second line therapy
  • soluble factors
  • sunitib resistance
  • TKIs
  • Traditional Chinese Medicine (TCM)
  • transcriptomic analysis
  • Treatment
  • Tyrosine kinase inhibitors

Links

DOI: 10.3390/books978-3-0365-2934-9

Editions

edition cover

Share

Copy/paste this into your site: